Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16063 | 28587078 | Nutrients | Morinda citrifolia Linn. (Noni) and Its Potential in Obesity-Related Metabolic Dysfunction. | 2017 | Details |
| A16064 | 28587063 | Int J Mol Sci | A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16065 | 28586417 | Fam Pract | Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China. | 2017 | Details |
| A16066 | 28586195 | ACS Chem Biol | Ex Vivo Cell-Based Screening Platform for Modulators of Hepatosteatosis. | 2017 | Details |
| A16067 | 28586172 | Hepatology | Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. | 2017 | Details |
| A16068 | 28586157 | J Ultrasound Med | Role of Point Shear Wave Elastography in the Determination of the Severity of Fibrosis in Pediatric Liver Diseases With Pathologic Correlations. | 2017 | Details |
| A16069 | 28585725 | Aliment Pharmacol Ther | Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population. | 2017 | Details |
| A16070 | 28585487 | Acta Chir Belg | Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes. | 2017 | Details |
| A16071 | 28585435 | Zool Res | Creating animal models, why not use the Chinese tree shrew (Tupaia belangeri chinensis)? | 2017 | Details |
| A16072 | 28585279 | J Dig Dis | Serum bile acid level and fatty acid composition in Chinese children with non-alcoholic fatty liver disease. | 2017 | Details |
| A16073 | 28585211 | Adv Exp Med Biol | Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16074 | 28585204 | Adv Exp Med Biol | Insulin Resistance, Obesity and Lipotoxicity. | 2017 | Details |
| A16075 | 28584294 | Sci Rep | Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver. | 2017 | Details |
| A16076 | 28581362 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ. | 2017 | Details |
| A16077 | 28581332 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. | 2017 | Details |
| A16078 | 28581252 | Liver Int | NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by 1 H-MRS? | 2017 | Details |
| A16079 | 28580850 | Orv Hetil | [Advances in the pathogenesis of non alcoholic fatty liver disease]. | 2017 | Details |
| A16080 | 28580278 | Mol Metab | FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis. | 2017 | Details |
| A16081 | 28579536 | Gastroenterology | Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. | 2017 | Details |
| A16082 | 28579247 | J Clin Lipidol | Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome. | 2017 | Details |
| A16083 | 28578672 | Lipids Health Dis | Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice. | 2017 | Details |
| A16085 | 28578014 | Free Radic Biol Med | Carbon monoxide protects against hepatic steatosis in mice by inducing sestrin-2 via the PERK-eIF2α-ATF4 pathway. | 2017 | Details |
| A16086 | 28577569 | Lipids Health Dis | Overexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes. | 2017 | Details |
| A16087 | 28577437 | Int Immunopharmacol | Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries. | 2017 | Details |
| A16088 | 28577304 | Int J Cancer | The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort. | 2017 | Details |
| A16089 | 28577247 | Dig Dis Sci | Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy. | 2017 | Details |
| A16090 | 28577233 | Biol Trace Elem Res | Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet. | 2017 | Details |
| A16092 | 28575232 | J Clin Endocrinol Metab | Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. | 2017 | Details |
| A16093 | 28574988 | PLoS One | The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study. | 2017 | Details |
| A16094 | 28573213 | ACS Cent Sci | Chemoproteomic Profiling of Bile Acid Interacting Proteins. | 2017 | Details |
| A16095 | 28573069 | World J Gastrointest Pathophysiol | Combination curcumin and vitamin E treatment attenuates diet-induced steatosis in Hfe-/- mice. | 2017 | Details |
| A16096 | 28573067 | World J Gastrointest Pathophysiol | Non-alcoholic fatty liver disease and cardiovascular risk. | 2017 | Details |
| A16097 | 28573066 | World J Gastrointest Pathophysiol | Embrionary way to create a fatty liver in portal hypertension. | 2017 | Details |
| A16098 | 28573064 | World J Gastrointest Pathophysiol | Nonalcoholic fatty liver disease: Diagnostic biomarkers. | 2017 | Details |
| A16099 | 28572039 | Dig Liver Dis | AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16100 | 28571771 | Food Chem Toxicol | The lemon balm extract ALS-L1023 inhibits obesity and nonalcoholic fatty liver disease in female ovariectomized mice. | 2017 | Details |
| A16102 | 28570941 | J Nutr Biochem | Diet-dependent retinoid effects on liver gene expression include stellate and inflammation markers and parallel effects of the nuclear repressor Shp. | 2017 | Details |
| A16103 | 28570615 | PLoS One | Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. | 2017 | Details |
| A16104 | 28570612 | PLoS One | Caveolin1 protects against diet induced hepatic lipid accumulation in mice. | 2017 | Details |
| A16105 | 28570343 | Eur J Gastroenterol Hepatol | Controlled attenuation parameter for diagnosing steatosis in bariatric surgery candidates with suspected nonalcoholic fatty liver disease. | 2017 | Details |
| A16106 | 28567448 | Sci Immunol | Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome. | 2017 | Details |
| A16107 | 28566439 | Eur J Endocrinol | MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. | 2017 | Details |
| A16108 | 28566408 | J Mol Endocrinol | 5-ALA ameliorates hepatic steatosis through AMPK signaling pathway. | 2017 | Details |
| A16109 | 28565851 | Exp Ther Med | Pharmacological management of non-alcoholic fatty liver disease: Atorvastatin versus pentoxifylline. | 2017 | Details |
| A16110 | 28562737 | Sao Paulo Med J | Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. | 2017 | Details |
| A16111 | 28562560 | Medicine (Baltimore) | Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects. | 2017 | Details |
| A16112 | 28562448 | Nurse Pract | The rising incidence of nonalcoholic fatty liver disease. | 2017 | Details |
| A16113 | 28560633 | Indian J Gastroenterol | Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India. | 2017 | Details |
| A16114 | 28559541 | Int J Obes (Lond) | Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis. | 2017 | Details |
| A16115 | 28558775 | Lipids Health Dis | Fat content, fatty acid pattern and iron content in livers of turkeys with hepatic lipidosis. | 2017 | Details |
| A16116 | 28558676 | BMC Endocr Disord | Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study. | 2017 | Details |
| A16117 | 31682383 | J Tradit Chin Med | Colon hydrotherapy plus Traditional Chinese Medicine to treat non-alcoholic fatty liver disease: a pilot study. | 2017 | Details |
| A16118 | 28555633 | Am J Gastroenterol | Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16119 | 28555525 | Immunopharmacol Immunotoxicol | Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease. | 2017 | Details |
| A16120 | 28554682 | Clin Gastroenterol Hepatol | Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. | 2017 | Details |
| A16121 | 28552096 | Dan Med J | The role of incretin hormones and glucagon in patients with liver disease. | 2017 | Details |
| A16122 | 28551355 | Trends Pharmacol Sci | Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance. | 2017 | Details |
| A16123 | 28551086 | Redox Biol | HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease. | 2017 | Details |
| A16124 | 28550439 | Obes Surg | Baseline Anthropometric and Metabolic Parameters Correlate with Weight Loss in Women 1-Year After Laparoscopic Roux-En-Y Gastric Bypass. | 2017 | Details |
| A16125 | 28550391 | Hepatol Int | Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. | 2017 | Details |
| A16126 | 28550272 | J Biomed Res | Non-alcoholic fatty liver disease--a chronic disease of the 21<sup>st</sup> century. | 2018 | Details |
| A16127 | 28549912 | Exp Cell Res | Fatty liver and FGF21 physiology. | 2017 | Details |
| A16129 | 28549240 | J Nutr Biochem | Dietary salecan reverts partially the metabolic gene expressions and NMR-based metabolomic profiles from high-fat-diet-induced obese rats. | 2017 | Details |
| A16130 | 28547778 | FEBS Lett | Deletion of HNF1α in hepatocytes results in fatty liver-related hepatocellular carcinoma in mice. | 2017 | Details |
| A16131 | 28546081 | Pharmacol Ther | Targeting nuclear receptors for the treatment of fatty liver disease. | 2017 | Details |
| A16132 | 28545937 | J Hepatol | Treatment of NAFLD with diet, physical activity and exercise. | 2017 | Details |
| A16133 | 28545373 | Curr Med Chem | Modulation of Aquaporins by Dietary Patterns and Plant Bioactive Compounds. | 2019 | Details |
| A16134 | 28545368 | Curr Med Chem | Improving Metabolic Control Through Functional Foods. | 2019 | Details |
| A16135 | 28544769 | Liver Int | Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy-proven NASH. | 2017 | Details |
| A16136 | 28544608 | Obes Rev | Screening for non-alcoholic fatty liver disease in children: do guidelines provide enough guidance? | 2017 | Details |
| A16137 | 28544258 | Liver Int | Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans. | 2017 | Details |
| A16138 | 28544245 | Diabetes Obes Metab | Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease. | 2017 | Details |
| A16139 | 28544208 | Liver Int | Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis. | 2017 | Details |
| A16140 | 28543915 | J Magn Reson Imaging | Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis. | 2017 | Details |
| A16141 | 28542544 | PLoS One | Development and characterization of an experimental model of diet-induced metabolic syndrome in rabbit. | 2017 | Details |
| A16142 | 28542113 | Eur J Gastroenterol Hepatol | Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
| A16143 | 28540988 | Yonsei Med J | Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis. | 2017 | Details |
| A16144 | 28540984 | Yonsei Med J | Inverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in Men. | 2017 | Details |
| A16145 | 28539915 | Front Microbiol | The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease. | 2017 | Details |
| A16146 | 28539716 | Pharmacogn Mag | Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-β-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 Cell. | 2017 | Details |
| A16147 | 28539530 | Endocr J | Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model. | 2017 | Details |
| A16148 | 28538192 | Biomed Pharmacother | Hepatic anti-inflammatory effect of hexane extracts of Dioscorea batatas Decne: Possible suppression of toll-like receptor 4-mediated signaling. | 2017 | Details |
| A16149 | 28537562 | Pol Przegl Chir | Impact of bariatric surgery on non-alcoholic fatty liver disease. | 2017 | Details |
| A16150 | 28536524 | Front Pharmacol | Mitotherapy for Fatty Liver by Intravenous Administration of Exogenous Mitochondria in Male Mice. | 2017 | Details |
| A16151 | 28536464 | Sci Rep | The protective effect of human renal sinus fat on glomerular cells is reversed by the hepatokine fetuin-A. | 2017 | Details |
| A16152 | 28536120 | FASEB J | Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor. | 2017 | Details |
| A16153 | 28535787 | BMC Infect Dis | Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C. | 2017 | Details |
| A16154 | 28534852 | Nutrients | Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. | 2017 | Details |
| A16155 | 28534819 | Int J Mol Sci | Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK. | 2017 | Details |
| A16156 | 28533742 | Front Mol Neurosci | Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms? | 2017 | Details |
| A16157 | 28533672 | World J Gastroenterol | Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. | 2017 | Details |
| A16158 | 28533304 | J Lipid Res | Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids. | 2017 | Details |
| A16159 | 28533225 | Clin Cancer Res | Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice. | 2017 | Details |
| A16160 | 28533219 | Mol Cell Biol | Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver. | 2017 | Details |
| A16161 | 28529818 | J Diabetes Metab | High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAs. | 2016 | Details |
| A16162 | 28529733 | Biomed Rep | Metabolic effects of Crocus sativus and protective action against non-alcoholic fatty liver disease in diabetic rats. | 2017 | Details |
| A16163 | 28529649 | Theranostics | SAK-HV Triggered a Short-period Lipid-lowering Biotherapy Based on the Energy Model of Liver Proliferation via a Novel Pathway. | 2017 | Details |
| A16164 | 28529199 | J Clin Res Pediatr Endocrinol | Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus? | 2017 | Details |
| A16165 | 28528267 | HPB (Oxford) | Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. | 2017 | Details |
| A16166 | 28527877 | Pharmacol Rep | Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. | 2017 | Details |